Home : November 2012 : November 08, 2012 News : ThromboGenics NV - Business Update

ThromboGenics NV - Business Update

November 08, 2012

LEUVEN, Belgium, November 8, 2012 /PRNewswire/ -- Regulated Information Disclosure in accordance with the law of May 2, 2007 ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, has...

http://www.prnewswire.com/news-releases/thrombogenics-nv---business-update-177907061.html
Other Stories